vs
Side-by-side financial comparison of HALOZYME THERAPEUTICS, INC. (HALO) and Simpson Manufacturing Co., Inc. (SSD). Click either name above to swap in a different company.
Simpson Manufacturing Co., Inc. is the larger business by last-quarter revenue ($588.0M vs $451.8M, roughly 1.3× HALOZYME THERAPEUTICS, INC.). Simpson Manufacturing Co., Inc. runs the higher net margin — 15.0% vs -31.3%, a 46.3% gap on every dollar of revenue. On growth, HALOZYME THERAPEUTICS, INC. posted the faster year-over-year revenue change (51.6% vs 9.1%). Over the past eight quarters, HALOZYME THERAPEUTICS, INC.'s revenue compounded faster (51.9% CAGR vs -0.8%).
Halozyme Therapeutics, Inc. is an American biotechnology company. It develops oncology therapies designed to target the tumor microenvironment.
Simpson Manufacturing Company is a leading building materials manufacturer in the United States that produces structural connectors, fasteners, anchors, and products for new construction and retrofitting.
HALO vs SSD — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $451.8M | $588.0M |
| Net Profit | $-141.6M | $88.2M |
| Gross Margin | 82.6% | 45.2% |
| Operating Margin | -20.6% | 19.5% |
| Net Margin | -31.3% | 15.0% |
| Revenue YoY | 51.6% | 9.1% |
| Net Profit YoY | -203.3% | 13.3% |
| EPS (diluted) | $-1.13 | $2.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $588.0M | ||
| Q4 25 | $451.8M | $539.3M | ||
| Q3 25 | $354.3M | $623.5M | ||
| Q2 25 | $325.7M | $631.1M | ||
| Q1 25 | $264.9M | $538.9M | ||
| Q4 24 | $298.0M | $517.4M | ||
| Q3 24 | $290.1M | $587.2M | ||
| Q2 24 | $231.4M | $597.0M |
| Q1 26 | — | $88.2M | ||
| Q4 25 | $-141.6M | $56.2M | ||
| Q3 25 | $175.2M | $107.4M | ||
| Q2 25 | $165.2M | $103.5M | ||
| Q1 25 | $118.1M | $77.9M | ||
| Q4 24 | $137.0M | $55.4M | ||
| Q3 24 | $137.0M | $93.5M | ||
| Q2 24 | $93.2M | $97.8M |
| Q1 26 | — | 45.2% | ||
| Q4 25 | 82.6% | 43.4% | ||
| Q3 25 | 84.4% | 46.4% | ||
| Q2 25 | 85.8% | 46.7% | ||
| Q1 25 | 81.7% | 46.8% | ||
| Q4 24 | 85.9% | 44.0% | ||
| Q3 24 | 83.0% | 46.8% | ||
| Q2 24 | 82.9% | 46.7% |
| Q1 26 | — | 19.5% | ||
| Q4 25 | -20.6% | 13.9% | ||
| Q3 25 | 61.5% | 22.6% | ||
| Q2 25 | 62.2% | 22.2% | ||
| Q1 25 | 53.4% | 19.0% | ||
| Q4 24 | 58.9% | 14.8% | ||
| Q3 24 | 56.3% | 21.3% | ||
| Q2 24 | 50.7% | 22.1% |
| Q1 26 | — | 15.0% | ||
| Q4 25 | -31.3% | 10.4% | ||
| Q3 25 | 49.5% | 17.2% | ||
| Q2 25 | 50.7% | 16.4% | ||
| Q1 25 | 44.6% | 14.5% | ||
| Q4 24 | 46.0% | 10.7% | ||
| Q3 24 | 47.2% | 15.9% | ||
| Q2 24 | 40.3% | 16.4% |
| Q1 26 | — | $2.13 | ||
| Q4 25 | $-1.13 | $1.34 | ||
| Q3 25 | $1.43 | $2.58 | ||
| Q2 25 | $1.33 | $2.47 | ||
| Q1 25 | $0.93 | $1.85 | ||
| Q4 24 | $1.06 | $1.31 | ||
| Q3 24 | $1.05 | $2.21 | ||
| Q2 24 | $0.72 | $2.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $133.8M | $341.0M |
| Total DebtLower is stronger | $2.1B | — |
| Stockholders' EquityBook value | $48.8M | $2.1B |
| Total Assets | $2.5B | $3.0B |
| Debt / EquityLower = less leverage | 43.89× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $341.0M | ||
| Q4 25 | $133.8M | $384.1M | ||
| Q3 25 | $419.7M | $297.3M | ||
| Q2 25 | $61.9M | $190.4M | ||
| Q1 25 | $176.3M | $150.3M | ||
| Q4 24 | $115.8M | $239.4M | ||
| Q3 24 | $154.3M | $339.4M | ||
| Q2 24 | $187.9M | $354.9M |
| Q1 26 | — | — | ||
| Q4 25 | $2.1B | $300.0M | ||
| Q3 25 | $1.5B | $371.3M | ||
| Q2 25 | $1.5B | $376.9M | ||
| Q1 25 | $1.5B | $382.5M | ||
| Q4 24 | $1.5B | $388.1M | ||
| Q3 24 | $1.5B | $393.8M | ||
| Q2 24 | $1.5B | $399.4M |
| Q1 26 | — | $2.1B | ||
| Q4 25 | $48.8M | $2.0B | ||
| Q3 25 | $503.9M | $2.0B | ||
| Q2 25 | $332.7M | $1.9B | ||
| Q1 25 | $482.3M | $1.9B | ||
| Q4 24 | $363.8M | $1.8B | ||
| Q3 24 | $452.7M | $1.9B | ||
| Q2 24 | $289.4M | $1.8B |
| Q1 26 | — | $3.0B | ||
| Q4 25 | $2.5B | $3.1B | ||
| Q3 25 | $2.2B | $3.0B | ||
| Q2 25 | $2.1B | $3.0B | ||
| Q1 25 | $2.2B | $2.8B | ||
| Q4 24 | $2.1B | $2.7B | ||
| Q3 24 | $2.1B | $2.9B | ||
| Q2 24 | $2.0B | $2.8B |
| Q1 26 | — | — | ||
| Q4 25 | 43.89× | 0.15× | ||
| Q3 25 | 3.00× | 0.19× | ||
| Q2 25 | 4.54× | 0.20× | ||
| Q1 25 | 3.13× | 0.21× | ||
| Q4 24 | 4.14× | 0.21× | ||
| Q3 24 | 3.32× | 0.21× | ||
| Q2 24 | 5.19× | 0.23× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $219.0M | — |
| Free Cash FlowOCF − Capex | $217.6M | — |
| FCF MarginFCF / Revenue | 48.2% | — |
| Capex IntensityCapex / Revenue | 0.3% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $644.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $219.0M | $155.7M | ||
| Q3 25 | $178.6M | $170.2M | ||
| Q2 25 | $99.7M | $125.2M | ||
| Q1 25 | $154.2M | $7.6M | ||
| Q4 24 | $178.5M | $115.8M | ||
| Q3 24 | $115.4M | $103.3M | ||
| Q2 24 | $55.8M | $111.1M |
| Q1 26 | — | — | ||
| Q4 25 | $217.6M | $119.0M | ||
| Q3 25 | $175.6M | $133.9M | ||
| Q2 25 | $98.1M | $87.3M | ||
| Q1 25 | $153.3M | $-42.6M | ||
| Q4 24 | $175.4M | $60.3M | ||
| Q3 24 | $113.9M | $58.1M | ||
| Q2 24 | $53.2M | $70.9M |
| Q1 26 | — | — | ||
| Q4 25 | 48.2% | 22.1% | ||
| Q3 25 | 49.6% | 21.5% | ||
| Q2 25 | 30.1% | 13.8% | ||
| Q1 25 | 57.9% | -7.9% | ||
| Q4 24 | 58.9% | 11.7% | ||
| Q3 24 | 39.3% | 9.9% | ||
| Q2 24 | 23.0% | 11.9% |
| Q1 26 | — | — | ||
| Q4 25 | 0.3% | 6.8% | ||
| Q3 25 | 0.9% | 5.8% | ||
| Q2 25 | 0.5% | 6.0% | ||
| Q1 25 | 0.4% | 9.3% | ||
| Q4 24 | 1.0% | 10.7% | ||
| Q3 24 | 0.5% | 7.7% | ||
| Q2 24 | 1.1% | 6.7% |
| Q1 26 | — | — | ||
| Q4 25 | — | 2.77× | ||
| Q3 25 | 1.02× | 1.58× | ||
| Q2 25 | 0.60× | 1.21× | ||
| Q1 25 | 1.31× | 0.10× | ||
| Q4 24 | 1.30× | 2.09× | ||
| Q3 24 | 0.84× | 1.10× | ||
| Q2 24 | 0.60× | 1.14× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HALO
| Royalty | $258.0M | 57% |
| Products | $122.7M | 27% |
| Proprietary Products Sales | $59.6M | 13% |
| Device Partnered Products | $12.9M | 3% |
SSD
Segment breakdown not available.
